Citi lowered the firm’s price target on DocuSign (DOCU) to $110 from $115 and keeps a Buy rating on the shares. After a strong finish last year, DocuSign’s Q1 results “were a frustrating set-back” with a true billings miss due to go-to-market changes driving fewer early renewals than anticipated, the analyst tells investors in a research note. The firm says the good news is DocuSign’s execution shortfall appears mostly timing-related.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign’s Earnings Call: Strong Growth Amid Caution
- DocuSign’s Stock Tumbles Amid Analyst Caution
- U.S. payrolls rise 139,000, Broadcom reports Q2 beat: Morning Buzz
- DocuSign price target lowered to $85 from $88 at BofA
- Morning Movers: Manchester United gains, Lululemon sinks after quarterly reports